Skip to main content
Top
Published in: BMC Infectious Diseases 1/2015

Open Access 01-12-2015 | Case report

Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review

Authors: Mayun Chen, Xiaomi Wang, Xianjuan Yu, Caijun Dai, Dunshun Chen, Chang Yu, Xiaomei Xu, Dan Yao, Li Yang, Yuping Li, Liangxing Wang, Xiaoying Huang

Published in: BMC Infectious Diseases | Issue 1/2015

Login to get access

Abstract

Background

Cryptococcus neoformans infection usually presents as chronic meningitis and is increasingly being recognized in immunocompromised patients. Presentation with pleural effusion is rare in cryptococcal disease; in fact, only 4 cases of pleural effusion as the initial clinical presentation in cryptococcosis have been reported in English-language literature to date. We report the first case of pleural effusion as the initial clinical presentation in a renal transplant recipient who was initially misdiagnosed with tuberculous pleuritis but who then developed fungaemia and disseminated cryptococcosis. The examination of this rare manifestation and the accompanying literature review will contribute to increased recognition of the disease and a reduction in misdiagnoses.

Case presentation

We describe a 63-year-old male renal transplant recipient on an immunosuppressive regimen who was admitted for left pleural effusion and fever. Cytological examinations and pleural fluid culture were nonspecific and negative. Thoracoscopy only found chronic, nonspecific inflammation with fibrosis in the pleura. After empirical anti-tuberculous therapy, the patient developed an elevated temperature, a severe headache and vomiting and fainted in the ward. Cryptococci were specifically found in the cerebrospinal fluid following lumbar puncture. Blood cultures were twice positive for C. neoformans one week later. He was transferred to the respiratory intensive care unit (RICU) immediately and was placed on non-invasive ventilation for respiratory failure for 2 days. He developed meningoencephalitis and fungaemia with C. neoformans during hospitalization. He was given amphotericin B liposome combined with 5-flucytosine and voriconazole for first 11 days, then amphotericin B liposome combined with 5-flucytosine sustained to 8 weeks, after that changed to fluconazole for maintenance. His condition improved after antifungal treatment, non-invasive ventilation and other support. Further pathological consultation and periodic acid-Schiff staining revealed Cryptococcus organisms in pleural sections, providing reliable evidence for cryptococcal pleuritis.

Conclusion

Pleural effusion is an unusual manifestation of cryptococcosis. Cryptococcal infection must be considered in the case of patients on immunosuppressives, especially solid-organ transplant recipients, who present with pleural effusion, even if pleural fluid culture is negative. Close communication between the pathologist and the clinician, multiple special biopsy section stains and careful review are important and may contribute to decreasing misdiagnosis.
Literature
1.
go back to reference Baddley JW, Forrest GN, Practice ASTIDCo. Cryptococcosis in solid organ transplantation. Am J Transplant. 2013;13 Suppl 4:242–9.CrossRefPubMed Baddley JW, Forrest GN, Practice ASTIDCo. Cryptococcosis in solid organ transplantation. Am J Transplant. 2013;13 Suppl 4:242–9.CrossRefPubMed
2.
go back to reference John GT, Mathew M, Snehalatha E, Anandi V, Date A, Jacob CK, et al. Cryptococcosis in renal allograft recipients. Transplantation. 1994;58(7):855–6.CrossRefPubMed John GT, Mathew M, Snehalatha E, Anandi V, Date A, Jacob CK, et al. Cryptococcosis in renal allograft recipients. Transplantation. 1994;58(7):855–6.CrossRefPubMed
3.
go back to reference Newman TG, Soni A, Acaron S, Huang CT. Pleural cryptococcosis in the acquired immune deficiency syndrome. Chest. 1987;91(3):459–61.CrossRefPubMed Newman TG, Soni A, Acaron S, Huang CT. Pleural cryptococcosis in the acquired immune deficiency syndrome. Chest. 1987;91(3):459–61.CrossRefPubMed
4.
go back to reference Katz AS, Niesenbaum L, Mass B. Pleural effusion as the initial manifestation of disseminated cryptococcosis in acquired immune deficiency syndrome. Diagnosis by pleural biopsy. Chest. 1989;96(2):440–1.CrossRefPubMed Katz AS, Niesenbaum L, Mass B. Pleural effusion as the initial manifestation of disseminated cryptococcosis in acquired immune deficiency syndrome. Diagnosis by pleural biopsy. Chest. 1989;96(2):440–1.CrossRefPubMed
5.
go back to reference Hsieh C-L, Chiang C-H, Perng R-P. Pleural effusion as the initial clinical presentation in pulmonary cryptococcosis: a report of a case with unusual manifestation, and a literature review. Thorax Med. 2003;18(6):500–6. Hsieh C-L, Chiang C-H, Perng R-P. Pleural effusion as the initial clinical presentation in pulmonary cryptococcosis: a report of a case with unusual manifestation, and a literature review. Thorax Med. 2003;18(6):500–6.
6.
go back to reference Kinjo K, Satake S, Ohama T. Cryptococcal pleuritis developing in a patient on regular hemodialysis. Clin Nephrol. 2009;72(3):229–33.CrossRefPubMed Kinjo K, Satake S, Ohama T. Cryptococcal pleuritis developing in a patient on regular hemodialysis. Clin Nephrol. 2009;72(3):229–33.CrossRefPubMed
7.
go back to reference Young EJ, Hirsh DD, Fainstein V, Williams TW. Pleural effusions due to Cryptococcus neoformans: a review of the literature and report of two cases with cryptococcal antigen determinations. Am Rev Respir Dis. 1980;121(4):743–7.PubMed Young EJ, Hirsh DD, Fainstein V, Williams TW. Pleural effusions due to Cryptococcus neoformans: a review of the literature and report of two cases with cryptococcal antigen determinations. Am Rev Respir Dis. 1980;121(4):743–7.PubMed
8.
go back to reference Mitchell DH, Sorrell TC, Allworth AM, Heath CH, McGregor AR, Papanaoum K, et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis. 1995;20(3):611–6.CrossRefPubMed Mitchell DH, Sorrell TC, Allworth AM, Heath CH, McGregor AR, Papanaoum K, et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis. 1995;20(3):611–6.CrossRefPubMed
10.
go back to reference Lewis JL, Rabinovich S. The wide spectrum of cryptococcal infections. Am J Med. 1972;53(3):315–22.CrossRefPubMed Lewis JL, Rabinovich S. The wide spectrum of cryptococcal infections. Am J Med. 1972;53(3):315–22.CrossRefPubMed
11.
go back to reference Reeves DL, Butt E, Hammack RW. Torula infection of the lungs and central nervous system: report of six cases with three autopsies. Arch Intern Med. 1941;68(1):57–79.CrossRef Reeves DL, Butt E, Hammack RW. Torula infection of the lungs and central nervous system: report of six cases with three autopsies. Arch Intern Med. 1941;68(1):57–79.CrossRef
12.
go back to reference Lui G, Lee N, Ip M, Choi KW, Tso YK, Lam E, et al. Cryptococcosis in apparently immunocompetent patients. QJM. 2006;99(3):143–51.CrossRefPubMed Lui G, Lee N, Ip M, Choi KW, Tso YK, Lam E, et al. Cryptococcosis in apparently immunocompetent patients. QJM. 2006;99(3):143–51.CrossRefPubMed
13.
go back to reference Rozenbaum R, Goncalves AJ. Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis. 1994;18(3):369–80.CrossRefPubMed Rozenbaum R, Goncalves AJ. Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis. 1994;18(3):369–80.CrossRefPubMed
14.
go back to reference Chou CC, Chen CR, Lee LN, Kuo SH, Luh KT. Pulmonary cryptococcosis: clinical analysis and treatment of 14 cases. Taiwan yi xue hui za zhi. J Formos Med Assoc. 1987;86(5):459–66. Chou CC, Chen CR, Lee LN, Kuo SH, Luh KT. Pulmonary cryptococcosis: clinical analysis and treatment of 14 cases. Taiwan yi xue hui za zhi. J Formos Med Assoc. 1987;86(5):459–66.
15.
go back to reference Izumikawa K, Zhao Y, Motoshima K, Takazono T, Saijo T, Kurihara S, et al. A case of pulmonary cryptococcosis followed by pleuritis in an apparently immunocompetent patient during fluconazole treatment. Med Mycol. 2008;46(6):595–9.CrossRefPubMed Izumikawa K, Zhao Y, Motoshima K, Takazono T, Saijo T, Kurihara S, et al. A case of pulmonary cryptococcosis followed by pleuritis in an apparently immunocompetent patient during fluconazole treatment. Med Mycol. 2008;46(6):595–9.CrossRefPubMed
16.
go back to reference Salyer WR, Salyer DC, Baker RD. Primary complex of Cryptococcus and pulmonary lymph nodes. J Infect Dis. 1974;130(1):74–7.CrossRefPubMed Salyer WR, Salyer DC, Baker RD. Primary complex of Cryptococcus and pulmonary lymph nodes. J Infect Dis. 1974;130(1):74–7.CrossRefPubMed
17.
go back to reference Makadzange AT, McHugh G. New approaches to the diagnosis and treatment of cryptococcal meningitis. Semin Neurol. 2014;34(1):47–60.CrossRefPubMed Makadzange AT, McHugh G. New approaches to the diagnosis and treatment of cryptococcal meningitis. Semin Neurol. 2014;34(1):47–60.CrossRefPubMed
18.
go back to reference Yi X, Kong J, Zhu M, Zhang Y, Chen X, Zhong C. Pathological diagnosis and ultrastructure features of primary pulmonary cryptococcosis: a study of 27 cases. Chin J Pathol. 2003;33(5):424–8. Yi X, Kong J, Zhu M, Zhang Y, Chen X, Zhong C. Pathological diagnosis and ultrastructure features of primary pulmonary cryptococcosis: a study of 27 cases. Chin J Pathol. 2003;33(5):424–8.
19.
go back to reference Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010;50(8):1101–11.CrossRefPubMed Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010;50(8):1101–11.CrossRefPubMed
20.
go back to reference Husain S, Wagener MM, Singh N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis. 2001;7(3):375–81.CrossRefPubMedPubMedCentral Husain S, Wagener MM, Singh N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis. 2001;7(3):375–81.CrossRefPubMedPubMedCentral
21.
go back to reference Singh N, Dromer F, Perfect JR, Lortholary O. Cryptococcosis in solid organ transplant recipients: current state of the science. Clin Infect Dis. 2008;47(10):1321–7.CrossRefPubMedPubMedCentral Singh N, Dromer F, Perfect JR, Lortholary O. Cryptococcosis in solid organ transplant recipients: current state of the science. Clin Infect Dis. 2008;47(10):1321–7.CrossRefPubMedPubMedCentral
22.
go back to reference Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2010;50(3):291–322.CrossRefPubMed Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2010;50(3):291–322.CrossRefPubMed
23.
go back to reference Wen H. Chinese expert consensus on the strategies for treating cryptococcosis. Chin J Mycol. 2010;5(02):65–8. Wen H. Chinese expert consensus on the strategies for treating cryptococcosis. Chin J Mycol. 2010;5(02):65–8.
24.
go back to reference van Duin D, Cleare W, Zaragoza O, Casadevall A, Nosanchuk JD. Effects of voriconazole on Cryptococcus neoformans. Antimicrob Agents Chemother. 2004;48(6):2014–20.CrossRefPubMedPubMedCentral van Duin D, Cleare W, Zaragoza O, Casadevall A, Nosanchuk JD. Effects of voriconazole on Cryptococcus neoformans. Antimicrob Agents Chemother. 2004;48(6):2014–20.CrossRefPubMedPubMedCentral
25.
go back to reference Pappas PG. Therapy of cryptococcal meningitis in non-HIV-infected patients. Curr Infect Dis Rep. 2001;3(4):365–70.CrossRefPubMed Pappas PG. Therapy of cryptococcal meningitis in non-HIV-infected patients. Curr Infect Dis Rep. 2001;3(4):365–70.CrossRefPubMed
26.
go back to reference Bandettini R, Castagnola E, Calvillo M, Micalizzi C, Ravegnani M, Pescetto L, et al. Voriconazole for cryptococcal meningitis in children with leukemia or receiving allogeneic hemopoietic stem cell transplant. J Chemother. 2009;21(1):108–9.CrossRefPubMed Bandettini R, Castagnola E, Calvillo M, Micalizzi C, Ravegnani M, Pescetto L, et al. Voriconazole for cryptococcal meningitis in children with leukemia or receiving allogeneic hemopoietic stem cell transplant. J Chemother. 2009;21(1):108–9.CrossRefPubMed
27.
go back to reference Nierenberg NE, Thompson GR, Lewis JS, Hogan BK, Patterson TF. Voriconazole use and pharmacokinetics in combination with interferon-gamma for refractory cryptococcal meningitis in a patient receiving low-dose ritonavir. Med Mycol. 2010;48(3):532–6.CrossRefPubMed Nierenberg NE, Thompson GR, Lewis JS, Hogan BK, Patterson TF. Voriconazole use and pharmacokinetics in combination with interferon-gamma for refractory cryptococcal meningitis in a patient receiving low-dose ritonavir. Med Mycol. 2010;48(3):532–6.CrossRefPubMed
28.
go back to reference Sabbatani S, Manfredi R, Pavoni M, Consales A, Chiodo F. Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure. Mycopathologia. 2004;158(2):165–71.CrossRefPubMed Sabbatani S, Manfredi R, Pavoni M, Consales A, Chiodo F. Voriconazole proves effective in long-term treatment of a cerebral cryptococcoma in a chronic nephropathic HIV-negative patient, after fluconazole failure. Mycopathologia. 2004;158(2):165–71.CrossRefPubMed
29.
go back to reference Haddow LJ, Colebunders R, Meintjes G, Lawn SD, Elliott JH, Manabe YC, et al. Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis. 2010;10(11):791–802.CrossRefPubMedPubMedCentral Haddow LJ, Colebunders R, Meintjes G, Lawn SD, Elliott JH, Manabe YC, et al. Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis. 2010;10(11):791–802.CrossRefPubMedPubMedCentral
30.
go back to reference Lortholary O, Fontanet A, Memain N, Martin A, Sitbon K, Dromer F. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS. 2005;19(10):1043–9.CrossRefPubMed Lortholary O, Fontanet A, Memain N, Martin A, Sitbon K, Dromer F. Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France. AIDS. 2005;19(10):1043–9.CrossRefPubMed
31.
go back to reference Lanternier F, Chandesris MO, Poiree S, Bougnoux ME, Mechai F, Mamzer-Bruneel MF, et al. Cellulitis revealing a cryptococcosis-related immune reconstitution inflammatory syndrome in a renal allograft recipient. Am J Transplant. 2007;7(12):2826–8.CrossRefPubMed Lanternier F, Chandesris MO, Poiree S, Bougnoux ME, Mechai F, Mamzer-Bruneel MF, et al. Cellulitis revealing a cryptococcosis-related immune reconstitution inflammatory syndrome in a renal allograft recipient. Am J Transplant. 2007;7(12):2826–8.CrossRefPubMed
32.
go back to reference Tan DB, Yong YK, Tan HY, Kamarulzaman A, Tan LH, Lim A, et al. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis. HIV Med. 2008;9(5):307–16.CrossRefPubMed Tan DB, Yong YK, Tan HY, Kamarulzaman A, Tan LH, Lim A, et al. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis. HIV Med. 2008;9(5):307–16.CrossRefPubMed
33.
go back to reference Hartung T, von Aulock S, Freitag M, Hoxtermann S, Stucker M, Hoffmann K, et al. Blood cytokine response of low-dose molgramostim (rhGM-CSF)-treated patients. Cytokine. 2000;12(10):1570–4.CrossRefPubMed Hartung T, von Aulock S, Freitag M, Hoxtermann S, Stucker M, Hoffmann K, et al. Blood cytokine response of low-dose molgramostim (rhGM-CSF)-treated patients. Cytokine. 2000;12(10):1570–4.CrossRefPubMed
34.
go back to reference von Aulock S, Boneberg EM, Diterich I, Hartung T. Granulocyte colony-stimulating factor (filgrastim) treatment primes for increased ex vivo inducible prostanoid release. J Pharmacol Exp Ther. 2004;308(2):754–9.CrossRef von Aulock S, Boneberg EM, Diterich I, Hartung T. Granulocyte colony-stimulating factor (filgrastim) treatment primes for increased ex vivo inducible prostanoid release. J Pharmacol Exp Ther. 2004;308(2):754–9.CrossRef
35.
go back to reference Hartung T, Doecke WD, Bundschuh D, Foote MA, Gantner F, Hermann C, et al. Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions. Clin Pharmacol Ther. 1999;66(4):415–24.CrossRefPubMed Hartung T, Doecke WD, Bundschuh D, Foote MA, Gantner F, Hermann C, et al. Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions. Clin Pharmacol Ther. 1999;66(4):415–24.CrossRefPubMed
36.
go back to reference von Aulock S, Boneberg EM, Hartung T. Intermittent G-CSF (filgrastim) treatment cannot induce lymphocytosis in volunteers. Clin Pharmacol Ther. 2000;68(1):104. von Aulock S, Boneberg EM, Hartung T. Intermittent G-CSF (filgrastim) treatment cannot induce lymphocytosis in volunteers. Clin Pharmacol Ther. 2000;68(1):104.
Metadata
Title
Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review
Authors
Mayun Chen
Xiaomi Wang
Xianjuan Yu
Caijun Dai
Dunshun Chen
Chang Yu
Xiaomei Xu
Dan Yao
Li Yang
Yuping Li
Liangxing Wang
Xiaoying Huang
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2015
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-015-1132-4

Other articles of this Issue 1/2015

BMC Infectious Diseases 1/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.